Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.5100 (-4.9%) ($9.5100 - $9.5100) on Fri. Dec. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.8% (three month average) | RSI | 34 | Latest Price | $9.5100(-4.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(58%) IWC(53%) IWO(50%) IWM(49%) IWN(47%) | Factors Impacting EDIT price | EDIT will decline at least -2.4% in a week (0% probabilities). VIXM(-13%) VXX(-9%) XBI(-5%) XLU(-4%) SMH(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.4% (StdDev 4.8%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.87(-214.3%) | Resistance Level | $10.64 | 5 Day Moving Average | $9.78(-2.76%) | 10 Day Moving Average | $9.94(-4.33%) | 20 Day Moving Average | $10.64(-10.62%) | To recent high | -40.9% | To recent low | 0% | Market Cap | $591m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |